Ojjaara 150 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FT5JP
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,013
Award facts
- Contract value 100% obligated
- $19,013.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $19,013.32 to AmerSourceBergen Drug Corp for OJJAARA 150 MG tablets in quantities of 30 units. The contract, executed on January 13, 2026, with completion scheduled for February 4, 2026, represents a firm fixed-price procurement with no set-aside designation. The award was competitively competed and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order falls under AmerSourceBergen's parent company Cencora, Inc.'s broader Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031, which serves as the primary vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerSourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds substantial federal contract portfolios with the Defense Logistics Agency and serves critical medical procurement needs for military and veteran healthcare systems. The company's extensive experience fulfilling federal pharmaceutical requirements across multiple therapeutic domains, combined with its capability to compete successfully on an open basis, positions it as a key vendor for the department's medical supply chain operations. The underlying IDC with DLA encompasses specialty medications, brand-name and generic drugs, vaccines, and other critical medical commodities necessary for military treatment facilities and federal healthcare institutions worldwide.
Quick answers
Who was awarded contract SPE2DR26FT5JP?
SPE2DR26FT5JP was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26FT5JP worth?
The government has obligated $19,013 on SPE2DR26FT5JP.
Is contract SPE2DR26FT5JP an order under another contract?
Yes. SPE2DR26FT5JP is a delivery order under SPE2DR25D3201, an indefinite delivery contract.
Was contract SPE2DR26FT5JP competed?
The extent of competition for SPE2DR26FT5JP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award